Biologics Flashcards

1
Q

Anthrax biologic approved in

A

Raxibacumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anthrax drug approved in 2016

A

Obiltoxaximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nerve agent poisoning treatment approved with animal rule

A

Pyridostigmine brominde

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Animal rule requirements

A

1- well understood mechanism

2- effect demonstrated in more than one species

3- animal study endpoints clearly relate to desired benefit in humans

4- data allows for selection of an effective dose in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Animals used for approval of anthrax biologic (beginning with R)

A

White rabbits and cynomologus macaque nonhuman primates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Serogroups of cholera that cause outbreaks

A

01 and 0139

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cholera treatment

A

Generally, oral rehydrating solution

Also, give appropriate antibiotics to diminish the duration of the diarrhea

Zinc supplementation in children reduced the duration of illness and the volume of diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cholera Vaccines

A

Vaxchora- live attenuated indicated against serogroup 01

Only FDA approved

90% efficacy

Shanchol & Euvichol - 65% protection for up to 5 years in endemic areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mycobacterium avium complex

A

Affects people with compromised immune function

Fever, sweats, weight loss, abdominal pain, fatigue, chronic diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MAC treatment

A

Clarithromycin and azithromycin

Surgical treatment in drug resistant

Clofazamine- new drug in clinical trials; FDA granted special investigational drug access (use outside of clinical trials)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Expanded access uses

A

1- patient and physician both willing to participate

2- no comparable therapy available

3- probable risk less than disease

4- sufficient evidence of safety and effectiveness

5- no interference with completion of clinical investigation

6- protocol of use of the product

7- patient is unable to obtain the ID under another IND or to participate in a clinical trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mucormycosis

A

Several different diseases caused by infection with fungi murcomycetes that affects people with weak immune system/ steam cell transplantation /diabetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Murcomycosis treatment

A

Amphotericin B and isavuconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aspergillosis

A

Caused by a common mold

Usually by inhalation

People with weakened immune system at greater risk

Several types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anti-fungal treatment for mucormycosis and aspergillosis

A

Isavuconazole

3A4 inhibitors or inducers can affect drug concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly